A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate

NCT06844383 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

126

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer (Adenocarcinoma)
mCRPC (Metastatic Castration-resistant Prostate Cancer)

Interventions

DRUG: Talazoparib with enzalutamide
DRUG: Talazoparib

Sponsor

Prostate Cancer Clinical Trials Consortium

Collaborators

[object Object]
[object Object]
[object Object]